This inventor holds 1 USPTO granted patent. Top assignees: Immuno-Biological Laboratories Co., Ltd., The Noguchi Institute. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: **Masaki Kurogochi: Innovator in Antibody Glycosylation**
Introduction
Masaki Kurogochi is a prominent inventor based in Tokyo, Japan. He holds a patent that focuses on advancements in antibody preparation methods. His work contributes significantly to the field of biotechnology, particularly in creating antibodies with precise glycan structures.
Latest Patents
Kurogochi's notable patent is titled "Method for preparing glycan-hydrolyzed antibody, and homogeneous glycosylated antibody." This invention aims to provide a novel approach for producing N-glycan hydrolyzed antibodies or Fc fragments used for creating antibodies with homogeneous N-glycan structures. The methodology involves a detailed process, including determining the combination of endoglycosidases necessary for preparation and measuring N-glycans linked to antibodies. Kurogochi's technique offers detailed steps for achieving precise glycan structures, enhancing the efficacy of antibody-based applications.
Career Highlights
Throughout his career, Masaki Kurogochi has been associated with esteemed institutions such as the Noguchi Institute and Immuno-biological Laboratories Co., Ltd. His research and development efforts in these organizations have been pivotal in advancing the understanding of glycan structures in antibody preparation.
Collaborations
Kurogochi has collaborated with distinguished researchers like Takashi Shirai and Masako Mori. These partnerships have fostered an environment of innovation and knowledge sharing, contributing to the advancement of biotechnology and the development of new methods in antibody research.
Conclusion
Masaki Kurogochi's contributions to antibody glycosylation represent significant progress in biotechnological innovations. His patent and collaborative efforts aim to improve the precision of antibody preparations, which is essential for various therapeutic applications. As the field continues to evolve, Kurogochi’s work will undoubtedly leave a lasting impact on the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile